Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Pinook-USA
WARNING LETTER
•Pinook-USA•February 24, 2012

FDA WARNING_LETTER - Pinook-USA - February 24, 2012

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

On June 14, 2012, the FDA issued a Warning Letter to Pinook-USA following a February 23-24, 2012 inspection. The firm manufactures therapeutic massagers, including the Mini, iPRO, Beetle, Nano, Mirco, Medi Pro, and MP5. The FDA determined these products are actually powered muscle stimulators and electronic acupuncture devices, not massagers.

The devices are adulterated under Section 501(f)(1)(B) of the Act because Pinook-USA lacks an approved premarket approval (PMA) or investigational device exemption. They are also misbranded under Section 502(o) for failure to submit a 510(k) premarket notification, and under Section 502(t)(2) for failing to furnish required information under Section 519 and 21 CFR Part 803 (Medical Device Reporting).

Specific violations include failure to develop, maintain, and implement written Medical Device Reporting (MDR) procedures (21 CFR 803.17), and failure to establish and maintain procedures for receiving, reviewing, and evaluating complaints (21 CFR 820.198(a)). The firm's March 8, 2012 response to the FDA 483 was deemed inadequate as it did not fully address MDR procedure development, implementation, or

Company
Pinook-USA
Inspection Date
February 24, 2012
Product Type
Devices
Office
Florida District Office
Person
  • Emma R. Singleton (District Director)
Open in Dashboard

ID · 6de10825-28f5-41a9-88ff-9448785fa246

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(f)(1)(B)21 U.S.C. 360e(a)21 U.S.C. 360j(g)21 U.S.C. 352(o)21 U.S.C. 360(k)21 CFR 807.81(b)21 U.S.C. 352(t)(2)21 U.S.C. 360i21 CFR 803

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.